NOT-TR-21-020: Notice of Early Expiration for PAR-19-337 "Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)"

Notice of Early Expiration for PAR-19-337 "Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)"

Notice Number:

NOT-TR-21-020

Key Dates

Release Date:

February 16, 2021

Related Announcements

PAR-19-337 - Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

This Notice informs applicants of the early expiration for Funding Opportunity Announcement (FOA) PAR-19-337, "Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional). Due to the early expiration, the final September 27, 2021 application due date is eliminated, effective immediately. No additional receipt dates will be issued for this FOA.

Inquiries

Please direct all inquiries to:

Pablo Cure, MD., MPH.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-2014
Email: [email protected]